Rein Therapeutics (RNTX) Accumulated Depreciation (2016 - 2023)
Rein Therapeutics' Accumulated Depreciation came in at $358,000 for Q4 2023, up 32.6% from $270,000 a year earlier and up 21.4% from the prior quarter.
Powered by 
Analysis
Rein Therapeutics (RNTX) Accumulated Depreciation (2016 - 2023) Analysis & Trends
Going back to Q4 2016, Rein Therapeutics' Accumulated Depreciation data covers 20 quarters.
- Accumulated Depreciation has increased in each of the last three years, though with a five-year compound annual growth rate of -21.6% (FY2018 to FY2023).
- Going back by year, Accumulated Depreciation was $270,000 in FY2022 (+27.4%), $212,000 in FY2021 (+27.7%), $166,000 in FY2020 (-68.2%) and $522,000 in FY2019 (-56.7%).
- The Q4 2023 figure represents the highest quarterly Accumulated Depreciation since Q3 2020.
- Year-over-year, Accumulated Depreciation has increased for nine consecutive quarters, with growth averaging 26.5% over the last eight quarters.
- The fastest year-over-year change in Accumulated Depreciation over five years came in Q1 2022 (growth of 35.1%), and the weakest in Q2 2021 (a decline of 70.4%).
- Business Quant data shows RNTX's Accumulated Depreciation at $295,000 (Q3 2023), $285,000 (Q2 2023) and $272,000 (Q1 2023) in the three quarters before Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Rein Therapeutics | 53.67 Mn | 53.67 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 358,000.00 |
| Sep 30, 2023 | 295,000.00 |
| Jun 30, 2023 | 285,000.00 |
| Mar 31, 2023 | 272,000.00 |
| Dec 31, 2022 | 270,000.00 |
| Sep 30, 2022 | 256,000.00 |
| Jun 30, 2022 | 240,000.00 |
| Mar 31, 2022 | 227,000.00 |
| Dec 31, 2021 | 212,000.00 |
| Sep 30, 2021 | 196,000.00 |
| Jun 30, 2021 | 181,000.00 |
| Mar 31, 2021 | 168,000.00 |
| Dec 31, 2020 | 166,000.00 |
| Sep 30, 2020 | 629,000.00 |
| Jun 30, 2020 | 612,000.00 |
| Mar 31, 2020 | 547,000.00 |
| Dec 31, 2019 | 522,000.00 |
| Dec 31, 2018 | 1.21 Mn |
| Dec 31, 2017 | 1.98 Mn |
| Dec 31, 2016 | 2.09 Mn |
API Access
Rein Therapeutics Accumulated Depreciation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=RNTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-depreciation", "ticker": "RNTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=RNTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();